Report Detail
Global Age Related Macular Degeneration Drug Market Insights, Forecast to 2025
- RnM3021725 |
- 04 April, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail.
Age Related Macular Degeneration Drug is widely used in hospitals, clinics and other field. The most proportion of Age Related Macular Degeneration Drug is used in Hospital, and the proportion in 2017 is 72%.
North America is the largest consumption place, with a consumption market share nearly 65.6% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
The global Age Related Macular Degeneration Drug market is valued at 6080 million US$ in 2018 and will reach 9620 million US$ by the end of 2025, growing at a CAGR of 5.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Age Related Macular Degeneration Drug market based on company, product type, end user and key regions.
This report studies the global market size of Age Related Macular Degeneration Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Age Related Macular Degeneration Drug in these regions.
This research report categorizes the global Age Related Macular Degeneration Drug market by top players/brands, region, type and end user. This report also studies the global Age Related Macular Degeneration Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma
Market size by Product
Lucentis
Eylea
Avastin
Other
Market size by End User
Hospitals
Clinics
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Age Related Macular Degeneration Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Age Related Macular Degeneration Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Age Related Macular Degeneration Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Age Related Macular Degeneration Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Age Related Macular Degeneration Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Age Related Macular Degeneration Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Age Related Macular Degeneration Drug Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Age Related Macular Degeneration Drug Market Size Growth Rate by Product
- 1.4.2 Lucentis
- 1.4.3 Eylea
- 1.4.4 Avastin
- 1.4.5 Other
- 1.5 Market by End User
- 1.5.1 Global Age Related Macular Degeneration Drug Market Size Growth Rate by End User
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Age Related Macular Degeneration Drug Market Size
- 2.1.1 Global Age Related Macular Degeneration Drug Revenue 2014-2025
- 2.1.2 Global Age Related Macular Degeneration Drug Sales 2014-2025
- 2.2 Age Related Macular Degeneration Drug Growth Rate by Regions
- 2.2.1 Global Age Related Macular Degeneration Drug Sales by Regions
- 2.2.2 Global Age Related Macular Degeneration Drug Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Age Related Macular Degeneration Drug Sales by Manufacturers
- 3.1.1 Age Related Macular Degeneration Drug Sales by Manufacturers
- 3.1.2 Age Related Macular Degeneration Drug Sales Market Share by Manufacturers
- 3.1.3 Global Age Related Macular Degeneration Drug Market Concentration Ratio (CR5 and HHI)
- 3.2 Age Related Macular Degeneration Drug Revenue by Manufacturers
- 3.2.1 Age Related Macular Degeneration Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Age Related Macular Degeneration Drug Revenue Share by Manufacturers (2014-2019)
- 3.3 Age Related Macular Degeneration Drug Price by Manufacturers
- 3.4 Age Related Macular Degeneration Drug Manufacturing Base Distribution, Product Types
- 3.4.1 Age Related Macular Degeneration Drug Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Age Related Macular Degeneration Drug Product Type
- 3.4.3 Date of International Manufacturers Enter into Age Related Macular Degeneration Drug Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Age Related Macular Degeneration Drug Sales by Product
- 4.2 Global Age Related Macular Degeneration Drug Revenue by Product
- 4.3 Age Related Macular Degeneration Drug Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Age Related Macular Degeneration Drug Breakdown Data by End User
6 North America
- 6.1 North America Age Related Macular Degeneration Drug by Countries
- 6.1.1 North America Age Related Macular Degeneration Drug Sales by Countries
- 6.1.2 North America Age Related Macular Degeneration Drug Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Age Related Macular Degeneration Drug by Product
- 6.3 North America Age Related Macular Degeneration Drug by End User
7 Europe
- 7.1 Europe Age Related Macular Degeneration Drug by Countries
- 7.1.1 Europe Age Related Macular Degeneration Drug Sales by Countries
- 7.1.2 Europe Age Related Macular Degeneration Drug Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Age Related Macular Degeneration Drug by Product
- 7.3 Europe Age Related Macular Degeneration Drug by End User
8 Asia Pacific
- 8.1 Asia Pacific Age Related Macular Degeneration Drug by Countries
- 8.1.1 Asia Pacific Age Related Macular Degeneration Drug Sales by Countries
- 8.1.2 Asia Pacific Age Related Macular Degeneration Drug Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Age Related Macular Degeneration Drug by Product
- 8.3 Asia Pacific Age Related Macular Degeneration Drug by End User
9 Central & South America
- 9.1 Central & South America Age Related Macular Degeneration Drug by Countries
- 9.1.1 Central & South America Age Related Macular Degeneration Drug Sales by Countries
- 9.1.2 Central & South America Age Related Macular Degeneration Drug Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Age Related Macular Degeneration Drug by Product
- 9.3 Central & South America Age Related Macular Degeneration Drug by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Age Related Macular Degeneration Drug by Countries
- 10.1.1 Middle East and Africa Age Related Macular Degeneration Drug Sales by Countries
- 10.1.2 Middle East and Africa Age Related Macular Degeneration Drug Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Age Related Macular Degeneration Drug by Product
- 10.3 Middle East and Africa Age Related Macular Degeneration Drug by End User
11 Company Profiles
- 11.1 Regeneron Pharmaceuticals
- 11.1.1 Regeneron Pharmaceuticals Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Products Offered
- 11.1.5 Regeneron Pharmaceuticals Recent Development
- 11.2 Bayer HealthCare
- 11.2.1 Bayer HealthCare Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Bayer HealthCare Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Bayer HealthCare Age Related Macular Degeneration Drug Products Offered
- 11.2.5 Bayer HealthCare Recent Development
- 11.3 Novartis
- 11.3.1 Novartis Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Novartis Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Novartis Age Related Macular Degeneration Drug Products Offered
- 11.3.5 Novartis Recent Development
- 11.4 Roche
- 11.4.1 Roche Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Roche Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Roche Age Related Macular Degeneration Drug Products Offered
- 11.4.5 Roche Recent Development
- 11.5 Kanghong Pharma
- 11.5.1 Kanghong Pharma Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Kanghong Pharma Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Kanghong Pharma Age Related Macular Degeneration Drug Products Offered
- 11.5.5 Kanghong Pharma Recent Development
12 Future Forecast
- 12.1 Age Related Macular Degeneration Drug Market Forecast by Regions
- 12.1.1 Global Age Related Macular Degeneration Drug Sales Forecast by Regions 2019-2025
- 12.1.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Regions 2019-2025
- 12.2 Age Related Macular Degeneration Drug Market Forecast by Product
- 12.2.1 Global Age Related Macular Degeneration Drug Sales Forecast by Product 2019-2025
- 12.2.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Product 2019-2025
- 12.3 Age Related Macular Degeneration Drug Market Forecast by End User
- 12.4 North America Age Related Macular Degeneration Drug Forecast
- 12.5 Europe Age Related Macular Degeneration Drug Forecast
- 12.6 Asia Pacific Age Related Macular Degeneration Drug Forecast
- 12.7 Central & South America Age Related Macular Degeneration Drug Forecast
- 12.8 Middle East and Africa Age Related Macular Degeneration Drug Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Age Related Macular Degeneration Drug Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Age Related Macular Degeneration Drug . Industry analysis & Market Report on Age Related Macular Degeneration Drug is a syndicated market report, published as Global Age Related Macular Degeneration Drug Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Age Related Macular Degeneration Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
